Evaxion (EVAX) 2026 Earnings: A Clear Commercial Outlook
Evaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesEvaxion's Q1 2026 results shed light on how its AI-driven drug discovery model is translating into collaborations and...
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
NextHome opens two Southern California offices, extending its coastal footprint with about 200 agents under a revampe...
A senior strategist at a massive $1.8 trillion fund warns that long-dated Treasuries are unlikely to shield retiremen...
Rumble faces a pivotal quarter as it navigates growth, monetization, and cost control. This article breaks down what ...
As BioHarvest gears up for its Q1 2026 earnings, investors seek clarity on revenue momentum, margins, and the path to...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
Redfin highlights several Midwest areas as hot markets. This guide breaks down what that means for investors, loan op...
A rapid-growth software startup markets a scrolling-based monetization model and seeks pre-IPO investors at $0.50 a s...
As the semiconductor cycle broadens, investors are flocking to TSMC on its diversified AI chip manufacturing capabili...
NIO posted a 62% year-over-year jump in May deliveries, sending stock higher as it rolls out new models. Tesla edged ...
A powerful wave of industry consolidation in 2026 is reshaping energy markets, elevating takeover risk for select sma...